Virbac SA

As of December 31, 2025, Virbac SA carries a market capitalization of 2.98B, placing it among publicly traded companies globally. Its enterprise value stands at 3.15B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Virbac SA's next confirmed earnings release is scheduled for March 23, 2027.

As of December 31, 2025, Virbac SA has 8.38M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Virbac SA maintains a current ratio of 1.53, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, Virbac SA's stock has declined approximately 1.55% over the past 52 weeks. The 50-day moving average sits at 320.86, while the 200-day moving average is 343.10.

As of December 31, 2025, Virbac SA holds 122.50M in cash and equivalents against 288.83M in total debt, resulting in a net debt position of 127.36M. Total book value stands at 1.13B, with working capital of 275.58M providing operational flexibility.

Virbac SA's most recent stock split took place on July 30, 2002 with a 1:4 split ratio.